STM
Journals
—
Open Access
Special Issue
Topic

COVID-19 Vaccination, and Female Fertility

Guest Editor:

        • Abstract Submission Deadline : 30/11/2023

        Manuscript Submission Deadline : 25/12/2023

        [This article belongs to Special Issue COVID-19 Vaccination, and Female Fertility under section ijbb, ijbb in (ijbb, ijbb)]

        Special Issue Description

        The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes the coronavirus illness 2019 (COVID-19) has sparked an unparalleled worldwide health disaster. Numerous COVID-19 vaccines are being developed, approved, and manufactured quickly due to their devastating effects. mRNA vaccines are one of them and are thought to be the best candidates with unique benefits to solve this problem. However, certain severe adverse effects have been linked to their use, raising major issues regarding the efficiency and safety of the vaccines as well as the value of immunization. There is no disputing the paucity of available evidence, which is one of the factors contributing to vaccine resistance in the general population, particularly among pregnant women, even though several fertility societies have stated that COVID-19 mRNA vaccines are unlikely to affect fertility. Here, we go into great detail about how the male and female reproductive systems are affected by SARS-CoV-2 infection or vaccination. On the one hand, COVID-19 could pose a serious hazard to human reproductive health despite the minimal chance of infection in the male reproductive system or fetus. Contrarily, our analysis shows that neither men nor women, particularly pregnant women, experience any issues with infertility or an increase in unfavorable pregnancy outcomes following vaccination. In particular, the advantages of maternal antibodies transmitted through the placenta outweigh any known or potential risks. Therefore, even if more research is still needed, particularly a larger population-based longitudinal study, it is unquestionably a sensible choice to get vaccinated rather than experience severe negative effects of virus infection in the case of the rapid spread of COVID-19 .

        Editor Keywords

        COVID-19, SARS-CoV-2, Fertility, mRNA, Vaccines

        Manuscript Submission information

        Manuscripts should be submitted online by registering and logging in to this link. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed.
        Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent on email address:[email protected] for announcement on this website.

        Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page.

        Participating journals:

        Journal Name

        International Journal of Biochemistry and Biomolecules, International Journal of Biochemistry and Biomolecules

        Abbrivation

        ijbb, ijbb

        ISSN

        Since

        APC

          $